Prevention of depression with escitalopram in patients undergoing treatment for head and neck cancer: randomized, double-blind, placebo-controlled clinical trial by Lydiatt William M, Bessette Diane, Schmid Kendra K, Sayles Harlan, Burke William J in JAMA otolaryngology-- head & neck surgery (2013). PubMed

Abstract

Major depressive disorder develops in up to half the patients undergoing treatment for head and neck cancer, resulting in significant morbidity; therefore, preventing depression during cancer treatment may be of great benefit.

[ hide abstract ]

Discussed In Paper